Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03545126 · ClinicalTrials.gov registry record
Human CNS Tau Kinetics in Tauopathies
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 27
- Enrollment target
NCT03545126 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 27 participants.
The verdict
NCT03545126 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
The goal of this study is to characterize tau kinetics and tau aggregation in the human CNS and to test the hypothesis that tau kinetics are altered (i.e. increased production, decreased clearance, and increased aggregation rate) in tauopathies.
Interventions
- OTHER 13C6 Leucine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2017-08-21 |
| Est. Completion | 2022-03-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03545126
The ClinicalTrials.gov registry entry for NCT03545126 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 13C6 Leucine is the first listed.
NCT03545126 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03545126 about?
NCT03545126 is a clinical study titled "Human CNS Tau Kinetics in Tauopathies". The goal of this study is to characterize tau kinetics and tau aggregation in the human CNS and to test the hypothesis that tau kinetics are altered (i.e. increased production, decreased clearance, and increased aggregation rate) in tauopathies.
What is the current status of trial NCT03545126?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2017-08-21. Estimated completion is 2022-03-04.
What interventions are being tested in trial NCT03545126?
The interventions under investigation include: 13C6 Leucine (OTHER).
Who is sponsoring clinical trial NCT03545126?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.